Scientific progress is built on failure
Learning to handle failure is just part of scientific life, writes Eileen Parkes.
Related Articles
Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
Oncogene – Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
Equitable machine learning counteracts ancestral bias in precision medicine
Nature Communications – Ancestral bias in cancer genomic datasets limits the effectiveness of precision medicine. Here, the authors introduce PhyloFrame, a machine learning framework that…
Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB–IIIA non-small-cell lung cancer
Nature Medicine – Exploratory post hoc analysis of molecular residual disease from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR-mutated stage IB–IIIA…
Management of the patent ductus arteriosus among infants born at 23 to 32 weeks’ gestation between 2011 to 2022: a report from in the Children’s Hospitals Neonatal Consortium
Journal of Perinatology – Management of the patent ductus arteriosus among infants born at 23 to 32 weeks’ gestation between 2011 to 2022: a report…
Unique events improve episodic richness, enhance mood, and alter the perception of time during isolation
Scientific Reports – Unique events improve episodic richness, enhance mood, and alter the perception of time during isolation
Nature exposure induces analgesic effects by acting on nociception-related neural processing
Nature Communications – Virtual nature exposure reduces self-reported pain and is associated with decreased brain responses linked to somatosensory and nociceptive processing, providing new…
Cell therapy for liver disorders: past, present and future
Nature Reviews Gastroenterology & Hepatology – The burden of liver disorders increases worldwide as does the necessity for new treatments. This Review discusses cell therapy…
An osteobiography of a celebrity chimpanzee reflects the changing roles of modern zoos
Scientific Reports – An osteobiography of a celebrity chimpanzee reflects the changing roles of modern zoos
ALK in cancer: from function to therapeutic targeting
Nature Reviews Cancer – ALK genetic alterations drive various malignancies through aberrant tyrosine kinase activation, promoting oncogenic cell growth and survival. Here, Voena et al.…
An axonal brake on striatal dopamine output by cholinergic interneurons
Nature Neuroscience – Cholinergic interneurons act at nicotinic receptors to depress dopamine release, interrupting its relationship to dopamine neuron firing and supporting an inverse scaling…
